pulmonary fibrosis

Pulmonary fibrosis is the lung's version of a scar that will not stop forming. After repeated injury, the body lays down excess collagen in the interstitium, much as a cut on the skin heals with tough scar tissue. But unlike a skin scar that eventually settles, this scarring can keep spreading, gradually replacing soft, stretchy lung with stiff fibrous tissue.

As scarring accumulates, the lungs lose volume and become hard to inflate, while the thickened walls slow the passage of oxygen into the blood. People typically notice creeping breathlessness and a dry cough, and over time may need supplemental oxygen. On CT, advanced disease shows distortion of the normal architecture, sometimes including honeycombing and traction bronchiectasis.

Fibrosis is a final common pathway rather than a single disease: it can follow idiopathic pulmonary fibrosis, connective-tissue diseases, chronic hypersensitivity pneumonitis, certain dusts, or some drugs. Established scar tissue generally cannot be reversed, so treatment aims to slow further progression, treat any reversible inflammation driving it, and support breathing and quality of life.

It is worth being honest that the outlook varies widely. Some fibrotic conditions stay stable for years, while others, particularly progressive forms, shorten life despite treatment. Identifying which pattern a person has, and whether the disease is actively progressing, guides how aggressively it is treated.